Details

---

Manufacturer: .

Novugen Pharma Sdn. Bhd

Registration number:

MAL22076044AZ

Contents

• Valsartan 160 mg

• Amlodipine besylate equivalent to Amlodipine 10 mg

Indication:

• Treatment of essential hypertension

• Particularly for patients whose blood pressure is not adequately controlled on monotherapy

Instructions:

• One tablet per day, orally, regardless of meals 

• Optional: Switching directly from individual amlodipine + valsartan tablets is acceptable for ease of adherence